Rabbit small intestine does not contain an annexin II/caveolin 1 complex as a target for 2-azetidinone cholesterol absorption inhibitors

Biochimica et Biophysica Acta - Biomembranes

Volumn 1758, Issue 1, 2006, Pages 45-54

  Kramer, Werner ^a   Corsiero, Daniel ^a   Girbig, Frank ^a   Jähne, Gerhard ^a  

^a SANOFI AVENTIS DEUTSCHLAND GMBH   (Germany)

Author keywords

Annexin II caveolin1; Brush border membrane (rabbit); Cholesterol absorption; Ezetimibe; Photoaffinity labelling

Indexed keywords

2 AZETIDINONE DERIVATIVE; ANTIBODY; AVE 5530; CAVEOLIN 1; CHOLESTEROL; CHOLESTEROL ABSORPTION INHIBITOR; EZETIMIBE; HYPOCHOLESTEROLEMIC AGENT; LIPOCORTIN 2; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOCHEMISTRY; BRUSH BORDER; COMPLEX FORMATION; CONTROLLED STUDY; CYTOSOL; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; IMMUNOREACTIVITY; INCUBATION TIME; INTESTINE ABSORPTION; INTESTINE CELL; ISOTOPE LABELING; MALE; MOUSE STRAIN; NONHUMAN; PHOTOAFFINITY LABELING; PHOTOREACTIVITY; PRIORITY JOURNAL; RABBIT; SMALL INTESTINE; ZEBRA FISH;

ABSORPTION; ANIMALS; ANNEXIN A2; ANTIBODIES; ANTICHOLESTEREMIC AGENTS; AZETIDINES; CAVEOLIN 1; CYTOPLASM; ENTEROCYTES; IMMUNOPRECIPITATION; INTESTINE, SMALL; MALE; MICROVILLI; RABBITS;

ANIMALIA; DANIO RERIO; ORYCTOLAGUS CUNICULUS;

EID: 33646447507     PISSN: 00052736     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamem.2005.12.007     Document Type: Article

References (33)

1. Harwood Jr. H.J., Chandler C.E., Pellarin L.D., Bangerter F.W., Wilkins R.W., Long C.A., Cosgrove P.G., Malinow M.R., Marzetta C.A., Pettini J.L., Savoy Y.E., and Mayne J.T. Pharmacological consequences of cholesterol absorption inhibition: alteration in cholesterol metabolism and reduction in plasma cholesterol concentration induced by the synthetic saponin beta-tigogenin cellobioside (CP-88818; tiqueside). J. Lipid Res. 34 (1993) 377-395
2. Burnett D.A., Caplen M.A., Davis Jr. H.R., Burrier R.E., and Clader J.W. 2-Azetidinones as inhibitors of cholesterol absorption. J. Med. Chem. 37 (1994) 1733-1736
3. Salen G., Ahrens E., and Grundy S. Metabolism of β-sitosterol in man. J. Clin. Invest. 49 (1970) 952-967
4. Dawson P.A., and Rudel L.L. Intestinal cholesterol absorption. Curr. Opin. Lipidol. 10 (1999) 315-320
5. Hauser H., Dyer J.H., Nandy A., Vega M.A., Werder M.A., Bieliauskaite E., Weber F.E., Compassi S., Gemperli A., Boffeli D., Wehrli E., Schulthess G., and Phillips M.C. Identification of a receptor mediating absorption of dietary cholesterol in the intestine. Biochemistry 37 (1998) 17843-17850
6. Lopez-Candale S.A., Bosner M.S., Spilburg C.A., and Lange L.G. Cholesterol transport function of pancreatic cholesterol esterase: directed sterol uptake and esterification in enterocytes. Biochemistry 32 (1993) 12085-12089
7. Repa J.J., Turley S.D., Lobacarro J.M.A., Medina J., Li L., Lustig K., Shan B., Heyman R.A., Dietschy J.D., and Mangelsdorf D.J. Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers. Science 289 (2000) 1524-2529
8. Lee M.H., Lu K., Hazard S., Yu H., Shulenin S., Hidaka H., Kojima H., Allikmets R., Sakama N., Pegoraro R., Srivastara A.K., Salen G., Dean M., and Patel S.B. Identification of a gene, ABCG5, important in the regulation of dietary cholesterol absorption. Nat. Genet. 27 (2001) 79-83
9. Berge K.E., Tian H., Graf G.A., Yu L., Grishin N.V., Schultz J., Kwiterovich P., Shan B., Barnes R., and Hobbs H.H. Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters. Science 290 (2000) 1771-1775
10. Van Heek M., Farley C., Compton D.S., Hoos L., Alton K.B., Sybertz E.J., and Davis Jr. H.R. Comparison of the activity and disposition of the novel cholesterol absorption inhibitor, SCH58235, and ist glucuronide, SCH60663. Br. J. Pharmacol. 129 (2000) 1748-1754
11. Kramer W., Glombik H., Petry S., Heuer H., Schäfer H.L., Wendler W., Corsiero D., Girbig F., and Weyland C. Identification of binding proteins for cholesterol absorption inhibitors as components of the intestinal cholesterol transporter. FEBS Lett. 487 (2000) 293-297
12. W. Kramer, H. Glombik, Protein extracted from the intestines of vertebrates, which absorbs cholesterol, and the use of this protein for identifiying inhibitors of intestinal cholesterol transport. International Patent Application WO 02/18432 (2000).
13. Frick W., Bauer-Schäfer A., Girbig F., Corsiero D., Heuer H., and Kramer W. Synthesis of a biotin-tagged photoaffinity probe of 2-azetidinone cholesterol absorption inhibitors. Bioorg. Med. Chem. 11 (2003) 1639-1642
14. Thiele C., Hannah M.J., Fahrenholz F., and Huttner W.B. Cholesterol binds to synaptophysin and is required for biosynthesis of synaptic vesicles. Nat. Cell Biol. 2 (2000) 42-49
15. Kramer W., Girbig F., Corsiero D., Burger K., Fahrenholz F., Glombik H., and Heuer H. Characterization and identification of the intestinal cholesterol uptake system. Bile Acids: From Genomics to Disease and Therapy (2003), Kluwer Academic Publishers, Dordrecht 147-160
16. Kramer W., Girbig F., Corsiero D., Burger K., Fahrenholz F., Jung C., and Müller G. Intestinal cholesterol absorption: identification of different binding proteins for cholesterol and cholesterol absorption inhibitors in the enterocyte brush border membrane. Biochim. Biophys. Acta 1633 (2003) 13-26
17. Kramer W., Girbig F., Corsiero D., Pfenninger A., Frick W., Jähne G., Rhein M., Wendler W., Lottspeich F., Hochleitner E.O., Orsó E., and Schmitz G. Aminopeptidase N (CD13) is a molecular target of the cholesterol absorption inhibitor ezetimibe in the enterocyte brush border membrane. J. Biol. Chem. 280 (2005) 1306-1320
18. Altmann S.W., Davies Jr. H.R., Zhu L.J., Yao X., Hoos L.M., Tetzloff G.N., Iyer S.P., Magaire M., Golorko A., Zeng M., Wang L., Murgolo N., and Graziano M.P. Niemann-Pick C1 like 1 protein is critical for intestinal cholesterol absorption. Science 303 (2004) 1201-1204
19. Garcia-Carlo M., Lisnock J., Bull H.G., Hawes B.E., Burnett D.A., Braun M.P., Crona J.H., Davis Jr. H.R., Dean D.C., Detmers P.A., Graziano M.P., Hughes M., MacIntyre D.E., Ogawa A., O'Neill K.A., Iyer S.P., Shevell D.E., Smith M.M., Tang Y.S., Makarewicz A.M., Ujjanwalla F., Altmann S.W., Chapman K.T., and Thornberry N.A. The target of ezetimibe is Niemann-Pick C1-like1 (NPC1L1). Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 8132-8137
20. Davies J.P., Scott C., Oishi K., Liapis A., and Ioannou Y.A. Inactivation of NPC1L1 causes multiple lipid transport defects and protects against diet-induced hypercholesterolemia. J. Biol. Chem. 280 (2005) 2710-2720
21. Smart E.J., De Rose R.A., and Farber S.A. Annexin 2-caveolin 1 complex is a target of ezetimibe and regulates intestinal cholesterol transport. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 3450-3455
22. H. Glombik, W. Kramer, S. Flohr, W. Frick, H. Heuer, G. Jaehne, A. Lindenschmidt, H.L. Schaefer, Novel 1,2-diphenylazetidinones, method for producing the same, medicaments containing said compounds, and the use thereof for treating disorders of the lipid metabolism. PCT Int. Patent Appl. WO 02/50027 (2002).
23. +-dependent bile acid transport activity in rabbit small intestine correlates with the coexpression of an integral 93 kDa and a peripheral 14 kDa bile acid-binding membrane protein along the duodenum-ileum axis. J. Biol. Chem. 268 (1993) 18035-18046
24. +/bile acid cotransporting protein form rabbit ileum. J. Biol. Chem. 276 (2001) 36020-36027
25. 3H]benzyl-penicillin. Biochem. Pharmacol. 37 (1988) 2427-2435
26. Cai T.Q., Guo Q., Wong B., Milot D., Zhang L., and Wright S.D. Protein-disulfide isomerase is a component of an NBD-cholesterol monomerizing protein complex from hamster small intestine. Biochim. Biophys. Acta 1581 (2002) 100-108
27. Field F.J., Born E., Murthy S., and Mathur S.N. Caveolin is present in intestinal cells: role in cholesterol trafficking?. J. Lipid Res. 39 (1998) 1938-1950
28. Gerke V., and Moss S.E. Annexins: from structure to function. Physiol. Rev. 82 (2002) 331-371
29. Harder T., and Gerke V. The subcellular distribution of early endosomes is affected by the annexin II 2p11 (2) complex. J. Cell Biol. 123 (1993) 1119-1132
30. Emans N., Gorrel J.P., Walter C., Gerke V., Kellner R., Griffith G., and Grueneberg J. Annexin II is a major component of fusogenic endosomal vesicles. J.Cellf Biol. 120 (1993) 1357-1369
31. Sarafian T., Pradel L.A., Henry J.P., Annis D., and Bader M.F. The participation of annexin II (calpactin I) in calcium-evoked exocytosis requires protein kinase C. J. Cell Biol. 114 (1991) 1135-1147
32. Mayran N., Parton R.G., and Grueneberg J. Annexin II regulates multivescular endosome biogenesis in the degradation pathway of animal cells. EMBO J. 22 (2003) 2353-3242
33. Valasek M.A., Weng J., Shaul P.W., Anderson R.G., and Repa J.J. Caveolin-1 is not required for murine intestinal cholesterol transport. J. Biol. Chem. 280 (2005) 28103-28109